All In MedTech

Company

Intera Oncology

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$3.7M

3 Form D offerings, 2019 to 2021

Equity

$3.7M

Stock sold for cash

Debt and convertible notes

$0

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $414K raised of $2.5M sought, first sale Jul 30, 2021, 8 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jul 30, 2021Equity$414K$2.5M8Rule 506(b)Form D ↗Aug 11, 2021

2 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
Intera Oncology Inc.
Headquarters
Wellesley Hills, Massachusetts
Incorporated
Delaware in 2019
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    5 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Intera Oncology.

    Latest FDA decisions

    Search the Clearance Tracker

    1 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    No device trials list this company as lead sponsor.

    Reports received

    121

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    78

    64% of reports

    Injury reports

    41

    34% of reports

    Death reports

    2

    1.7% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 235100
    Jan 243400
    Feb 2441000
    Mar 2416000
    Apr 248400
    May 241500
    Jun 246100
    Jul 245200
    Aug 245300
    Sep 247300
    Oct 247200
    Nov 244000
    Dec 247300
    Jan 258300
    Feb 258200
    Mar 257100
    Apr 257600
    May 2512200
    Jun 256300
    Jul 257400
    Aug 258200
    Sep 2511200
    Oct 256200
    Nov 259500
    Dec 258100
    Jan 266200
    Feb 266000
    Mar 266300
    Apr 2614600
    May 2612400
    Jun 268200
    Jul 261400
    Aug 263700
    Sep 263410
    Oct 262310
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    The full in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.